Form 8.3 - HORIZON THERAPEUTICS PLC

Barclays PLC

06 June 2023

 

FORM 8.3
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY
A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
Rule 8.3 of the Takeover Code (the "Code")
1.				KEY INFORMATION
(a)	Full name of discloser:				Barclays PLC.
(b)	Owner or controller of interest and short
	positions disclosed, if different from 1(a):
(c)	Name of offeror/offeree in relation to whose				HORIZON THERAPEUTICS PLC
	relevant securities this form relates:
(d)	If an exempt fund manager connected with an
	offeror/offeree, state this and specify identity of
	offeror/offeree:
(e)	Date position held/dealing undertaken:				05 Jun 2023
(f)	In addition to the company in 1(c) above, is the discloser making				NO
	disclosures in respect of any other party to the offer?
2.				POSITIONS OF THE PERSON MAKING THE DISCLOSURE
(a)	Interests and short positions in the relevant securities of the offeror or offeree
	to which the disclosure relates following the dealing(if any)
Class of relevant security:				$0.001 ordinary shares
				Interests		Short Positions
				Number	(%)	Number	(%)
(1)	Relevant securities owned
	and/or controlled:			1,087,377	0.48%	678,970	0.30%
(2)	Cash-settled derivatives:
	and/or controlled:			140,756	0.06%	98,064	0.04%
(3)	Stock-settled derivatives (including options)
	and agreements to purchase/sell:			1,422,500	0.62%	936,400	0.41%
	TOTAL:			2,650,633	1.16%	1,713,434	0.75%
(b)	Rights to subscribe for new securities (including directors and other executive
	options)
Class of relevant security in relation to
which subscription right exists
Details, including nature of the rights
concerned and relevant percentages:
3.				DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
(a)	Purchases and sales
Class of relevant		Purchase/sale		Number of		Price per unit
security				securities
$0.001 ordinary shares		Purchase		96		99.8275  USD
$0.001 ordinary shares		Purchase		27,501		99.8157  USD
$0.001 ordinary shares		Purchase		4,531		99.8554  USD
$0.001 ordinary shares		Sale		6,475		100.0142  USD
$0.001 ordinary shares		Purchase		4		99.9000  USD
$0.001 ordinary shares		Purchase		63		99.6900  USD
$0.001 ordinary shares		Purchase		557		100.0600  USD
$0.001 ordinary shares		Sale		9		99.7200  USD
$0.001 ordinary shares		Purchase		10,414		99.7349  USD
$0.001 ordinary shares		Sale		613		99.8168  USD
$0.001 ordinary shares		Purchase		21		99.8490  USD
$0.001 ordinary shares		Purchase		364		99.8180  USD
$0.001 ordinary shares		Purchase		14		99.8000  USD
$0.001 ordinary shares		Sale		87		99.8300  USD
$0.001 ordinary shares		Sale		201		99.9098  USD
$0.001 ordinary shares		Purchase		5		99.8660  USD
$0.001 ordinary shares		Purchase		1,786		99.8873  USD
$0.001 ordinary shares		Purchase		135		99.8568  USD
$0.001 ordinary shares		Sale		1		99.9200  USD
$0.001 ordinary shares		Purchase		176		99.8729  USD
$0.001 ordinary shares		Purchase		9		99.8033  USD
$0.001 ordinary shares		Sale		3,027		99.6700  USD
$0.001 ordinary shares		Purchase		10		99.8250  USD
$0.001 ordinary shares		Purchase		8		99.9375  USD
$0.001 ordinary shares		Purchase		2,900		99.6700  USD
$0.001 ordinary shares		Sale		1,453		99.9386  USD
$0.001 ordinary shares		Purchase		35		99.8567  USD
$0.001 ordinary shares		Purchase		1,650		100.0502  USD
$0.001 ordinary shares		Purchase		34		99.8651  USD
$0.001 ordinary shares		Purchase		2,041		100.0441  USD
$0.001 ordinary shares		Sale		3,407		99.8136  USD
$0.001 ordinary shares		Sale		2,801		99.8331  USD
$0.001 ordinary shares		Sale		10,267		99.7024  USD
$0.001 ordinary shares		Sale		15,758		99.7697  USD
$0.001 ordinary shares		Purchase		1,950		100.0700  USD
$0.001 ordinary shares		Purchase		38		99.8878  USD
$0.001 ordinary shares		Purchase		57		99.8431  USD
$0.001 ordinary shares		Purchase		99		99.9595  USD
$0.001 ordinary shares		Purchase		100		99.7500  USD
$0.001 ordinary shares		Sale		466		99.6986  USD
$0.001 ordinary shares		Sale		2,500		99.8165  USD
$0.001 ordinary shares		Sale		200		99.9060  USD
$0.001 ordinary shares		Sale		500		99.8756  USD
$0.001 ordinary shares		Purchase		14		99.8442  USD
$0.001 ordinary shares		Sale		5,716		99.8144  USD
$0.001 ordinary shares		Sale		694		99.8642  USD
$0.001 ordinary shares		Purchase		9		99.8200  USD
$0.001 ordinary shares		Purchase		2,756		99.8123  USD
$0.001 ordinary shares		Sale		649		99.7960  USD
$0.001 ordinary shares		Purchase		28		99.8835  USD
$0.001 ordinary shares		Purchase		211		99.9041  USD
$0.001 ordinary shares		Purchase		10,354		99.7035  USD
$0.001 ordinary shares		Sale		105		99.6985  USD
$0.001 ordinary shares		Sale		899		99.7955  USD
$0.001 ordinary shares		Purchase		2		99.8300  USD
$0.001 ordinary shares		Purchase		2		99.8850  USD
$0.001 ordinary shares		Sale		11		99.8700  USD
$0.001 ordinary shares		Sale		998		99.8088  USD
$0.001 ordinary shares		Sale		400		99.7700  USD
$0.001 ordinary shares		Sale		1,850		100.0700  USD
$0.001 ordinary shares		Sale		400		99.8545  USD
$0.001 ordinary shares		Sale		1,212		99.8313  USD
$0.001 ordinary shares		Purchase		7		99.6985  USD
$0.001 ordinary shares		Purchase		210		99.8723  USD
$0.001 ordinary shares		Sale		2,813		99.8160  USD
$0.001 ordinary shares		Purchase		7		99.8485  USD
$0.001 ordinary shares		Sale		5,510		99.8262  USD
$0.001 ordinary shares		Sale		12,191		99.6710  USD
$0.001 ordinary shares		Purchase		11		99.8400  USD
$0.001 ordinary shares		Purchase		359		100.0657  USD
$0.001 ordinary shares		Sale		294		99.6934  USD
$0.001 ordinary shares		Purchase		19		99.8089  USD
$0.001 ordinary shares		Purchase		698		99.8631  USD
$0.001 ordinary shares		Purchase		12,173		99.6710  USD
$0.001 ordinary shares		Purchase		4		99.8750  USD
$0.001 ordinary shares		Purchase		28		99.8192  USD
$0.001 ordinary shares		Sale		1,850		99.8220  USD
$0.001 ordinary shares		Purchase		12		99.8691  USD
$0.001 ordinary shares		Purchase		17		99.8711  USD
$0.001 ordinary shares		Purchase		2,038		99.8893  USD
$0.001 ordinary shares		Sale		200		99.8321  USD
(b)	Cash-settled derivative transactions
Class of		Product		Nature of dealing		Number of	Price per
relevant		description				reference	unit
security						securities
(c)	Stock-settled derivative transactions (including options)
(i)	Writing, selling, purchasing or varying
Class	Product	Writing,	Number	Exercise	Type	Expiry	Option
of	description	purchasing,	of	price		date	money
relevant		selling,	securities	per unit			paid/
security		varying etc	to which				received
			option				per unit
			relates
(ii)	Exercising
Class of relevant		Product description		Exercising/ exercised against		Number of	Exercise price per
security						securities	unit
(d)	Other dealings (including subscribing for new securities)
Class of relevant		Nature of Dealings		Details		Price per unit (if
security						applicable)
4.				OTHER INFORMATION
(a)	Indemnity and other dealings arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the disclosure and any party
to the offer or any person acting in concert with a party to the offer:
NONE
(b)	Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the person making the disclosure and any other person relating to:
(i)  the voting rights of any relevant securities under any option; or
(ii) the voting rights of future acquisition or disposal of any relevant securities to which
any derivative is referenced:
NONE
(c)	Attachments
Is a Supplemental Form 8 (Open Positions) attached?				YES
Date of disclosure:				06 Jun 2023
Contact name:				Large Holdings Regulatory Operations
Telephone number:				020 3134 7213
DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO
PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1.				KEY INFORMATION
Identity of the person whose positions/dealings				Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose				HORIZON THERAPEUTICS PLC
relevant securities this from relates:
2.				OPTIONS AND DERIVATIVES
Class of relevant security	Product description	Writing, purchasing, selling, varying etc	Number of securities to which option relates	Exercise price per unit	Type	Expiry date
$0.001 ordinary shares	Put Options	Purchased	-544,200	80.0000	American	18 Aug 2023
$0.001 ordinary shares	Put Options	Purchased	-250,000	80.0000	American	16 Jun 2023
$0.001 ordinary shares	Put Options	Purchased	-106,800	90.0000	American	21 Jul 2023
$0.001 ordinary shares	Put Options	Purchased	-10,200	100.0000	American	18 Aug 2023
$0.001 ordinary shares	Call Options	Written	-10,600	105.0000	American	18 Aug 2023
$0.001 ordinary shares	Call Options	Written	-10,000	105.0000	American	16 Jun 2023
$0.001 ordinary shares	Call Options	Written	-2,600	100.0000	American	18 Aug 2023
$0.001 ordinary shares	Call Options	Written	-2,000	100.0000	American	21 Jul 2023
$0.001 ordinary shares	Put Options	Written	2,000	85.0000	American	21 Jul 2023
$0.001 ordinary shares	Put Options	Written	10,200	80.0000	American	18 Aug 2023
$0.001 ordinary shares	Put Options	Written	28,800	95.0000	American	21 Jul 2023
$0.001 ordinary shares	Put Options	Written	74,000	90.0000	American	15 Sep 2023
$0.001 ordinary shares	Put Options	Written	162,000	105.0000	American	21 Jul 2023
$0.001 ordinary shares	Put Options	Written	250,000	105.0000	American	16 Jun 2023
$0.001 ordinary shares	Put Options	Written	400,000	100.0000	American	18 Aug 2023
$0.001 ordinary shares	Put Options	Written	495,500	100.0000	American	16 Jun 2023
3.				AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest or position can be fully understood:

 

END